Existing products: how far should firms go in evaluating new risks?
This article was originally published in Clinica
To what extent should manufacturers apply new standards to devices already on the market? That is the question being faced by all medical device companies, and especially those manufacturing products with the potential to cause electromagnetic interference or to be affected by it. Medical device consultant Trevor Lewis believes that changes in regulations and standards reflect changes in the Real World in which devices operate, and warns that companies must urgently face up to these, or risk potential product liability suits.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.